644 related articles for article (PubMed ID: 22803772)
1. Impact of traits of metabolic syndrome on β-cell function and insulin resistance in normal fasting, normal glucose tolerant subjects.
Cubeddu LX; Hoffmann IS
Metab Syndr Relat Disord; 2012 Oct; 10(5):344-50. PubMed ID: 22803772
[TBL] [Abstract][Full Text] [Related]
2. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC; Miranda WL; Chacra AR; Dib SA
J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
[TBL] [Abstract][Full Text] [Related]
4. Correlation between HDL cholesterol levels and beta-cell function in subjects with various degree of glucose tolerance.
Bardini G; Dicembrini I; Rotella CM; Giannini S
Acta Diabetol; 2013 Apr; 50(2):277-81. PubMed ID: 21997326
[TBL] [Abstract][Full Text] [Related]
5. Decreased beta cell function and insulin sensitivity contributed to increasing fasting glucose in Chinese.
Bi Y; Zhu D; Jing Y; Hu Y; Feng W; Shen S; Tong G; Shen X; Yu T; Song D; Yang D
Acta Diabetol; 2012 Dec; 49 Suppl 1():S51-8. PubMed ID: 20473530
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study.
Bianchi C; Miccoli R; Bonadonna RC; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Alviggi L; Gnasso A; Consoli A; Cavalot F; Cavallo MG; Leonetti F; Giaccari A; Del Prato S;
Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):699-705. PubMed ID: 21291660
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
Amoah AG; Schuster DP; Gaillard T; Osei K
Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
[TBL] [Abstract][Full Text] [Related]
8. [Role of insulin resistance and β cell function in the development of newly diagnosed type 2 diabetes].
Chen X; Su M; Wang C; Wu Z; Li S; Ying X; Wei G; Fu C; Jiang Q
Wei Sheng Yan Jiu; 2015 Nov; 44(6):881-6. PubMed ID: 26738376
[TBL] [Abstract][Full Text] [Related]
9. Associations of plasma glucose levels and traits of metabolic syndrome with carotid intima media thickness in nondiabetic elderly subjects: are they mediated by insulin resistance?
Viscogliosi G; Andreozzi P; Marigliano V
Metab Syndr Relat Disord; 2013 Feb; 11(1):41-5. PubMed ID: 23067236
[TBL] [Abstract][Full Text] [Related]
10. Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolism.
van der Zijl NJ; Goossens GH; Moors CC; van Raalte DH; Muskiet MH; Pouwels PJ; Blaak EE; Diamant M
J Clin Endocrinol Metab; 2011 Feb; 96(2):459-67. PubMed ID: 21084401
[TBL] [Abstract][Full Text] [Related]
11. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
[TBL] [Abstract][Full Text] [Related]
12. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels.
Utzschneider KM; Prigeon RL; Faulenbach MV; Tong J; Carr DB; Boyko EJ; Leonetti DL; McNeely MJ; Fujimoto WY; Kahn SE
Diabetes Care; 2009 Feb; 32(2):335-41. PubMed ID: 18957530
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel.
Shalitin S; Abrahami M; Lilos P; Phillip M
Int J Obes (Lond); 2005 Jun; 29(6):571-8. PubMed ID: 15889115
[TBL] [Abstract][Full Text] [Related]
14. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
[TBL] [Abstract][Full Text] [Related]
15. Association of traits of metabolic syndrome with glucose abnormalities.
Hoffmann IS; Cubeddu LX
Am J Ther; 2013; 20(4):363-8. PubMed ID: 23591026
[TBL] [Abstract][Full Text] [Related]
16. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].
Zhang XJ; Wang Z; Li HH; Yu L; Gao S
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671
[TBL] [Abstract][Full Text] [Related]
17. β-Cell dysfunction is associated with metabolic syndrome severity in adults.
Malin SK; Finnegan S; Fealy CE; Filion J; Rocco MB; Kirwan JP
Metab Syndr Relat Disord; 2014 Mar; 12(2):79-85. PubMed ID: 24283920
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III).
Muntner P; He J; Chen J; Fonseca V; Whelton PK
Ann Epidemiol; 2004 Oct; 14(9):686-95. PubMed ID: 15380800
[TBL] [Abstract][Full Text] [Related]
19. Glucoregulatory physiology in subjects with low-normal, high-normal, or impaired fasting glucose.
Dagogo-Jack S; Askari H; Tykodi G
J Clin Endocrinol Metab; 2009 Jun; 94(6):2031-6. PubMed ID: 19276238
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome: an all or none or a continuum load of risk?
Cubeddu LX; Hoffmann IS
Metab Syndr Relat Disord; 2012 Feb; 10(1):14-9. PubMed ID: 22032809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
